A Phase Ib/2 Clinical Study to Evaluate the Safety, Pharmacokinetic Characteristics and Preliminary Efficacy of Fruquintinib Combined With Paclitaxel in Patients With Advanced Gastric Cancer
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 02 Mar 2017
At a glance
- Drugs Fruquintinib (Primary) ; Paclitaxel
- Indications Gastric cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Hutchison MediPharma
- 23 Feb 2017 Planned End Date changed from 1 Feb 2017 to 31 Mar 2017.
- 23 Feb 2017 Planned primary completion date changed from 1 Dec 2016 to 31 Mar 2017.
- 23 Feb 2017 Status changed from recruiting to active, no longer recruiting.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History